FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
22 letters match. Newest first.
-
DrugsPro Numb Tattoo Numbing Spray, LLC
FDA cited Pro Numb Tattoo Numbing Spray for selling unapproved, misbranded numbing drugs and manufacturing quality failures after a November 2025 inspection.
High risk -
DrugsRC Outsourcing, LLC
FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.
High risk -
DrugsStaska Pharmaceuticals, Inc.
FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.
High risk -
DrugsAmazon.com, Inc.
Amazon sold unapproved numbing creams for tattoos and cosmetic procedures, FDA says.
High risk -
DrugsTKTX USA
FDA warned TKTX USA that its TKTX Numbing Creams are unapproved and misbranded drugs with lidocaine levels above OTC limits.
High risk -
DrugsTKTX Numb Store
FDA warned TKTX Numb Store that its lidocaine anesthetic creams are unapproved and misbranded drugs sold without a prescription.
High risk -
DrugsTKTX Store
FDA warns TKTX Store it sells unapproved lidocaine and prilocaine numbing creams online for tattooing and cosmetic procedures.
High risk -
DrugsTKTX Numbing Cream USA
FDA warned TKTX Numbing Cream USA that its lidocaine numbing creams are unapproved and misbranded new drugs.
High risk -
DrugsFagron Compounding Services, LLC dba Fagron Sterile Service
FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.
High risk -
DrugsCentura Pharmaceuticals Inc
FDA warned Centura Pharmaceuticals that its BLT 1-2-3 Cream, a mixed numbing product for cosmetic procedures, is an unapproved new drug.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.
High risk -
DrugsSky Bank Media, LLC dba Painless Tattoo Cream Co.
FDA warned Painless Tattoo Cream Co. that its numbing cream and spray are unapproved new drugs with excess lidocaine.
High risk -
DrugsTattoo Numbing Cream Co.
Tattoo Numbing Cream Co. sold Signature Tattoo Numbing Cream and Miracle Numb Spray as unapproved drugs for tattooing.
High risk -
DrugsDermal Source, Inc.
FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.
High risk -
DrugsSeeNext Venture, Ltd.
FDA warns SeeNext Venture over unapproved, misbranded NumbSkin lidocaine creams sold online.
High risk -
DrugsTKTX Company
TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.
High risk -
DrugsIndelicare DBA INKEEZE
FDA warns Indelicare that its INKEEZE lidocaine numbing gel, spray and foam soap are unapproved new drugs sold outside OTC limits.
High risk -
DrugsOmeza LLC
FDA warned Omeza LLC over mold, insects and animal waste in drug manufacturing areas and unapproved nonprescription drugs.
High risk -
DrugsSouthern Tier Home Infusion, Inc. dba Pharmacy Innovations
FDA warned compounding pharmacy Pharmacy Innovations that its sterile drugs were made under insanitary conditions and without valid patient prescriptions.
High risk -
DrugsCarolina Infusion
FDA warns Carolina Infusion over compounded drugs made without valid prescriptions and under insanitary conditions, including sterile products.
High risk -
DrugsKobayashi Healthcare International, Inc.
Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.
High risk -
DrugsAdvanced Cosmetic Research Laboratories Inc.
FDA cited Advanced Cosmetic Research Laboratories for manufacturing-quality violations at its Chatsworth drug plant and an unapproved 5% lidocaine cream.
High risk